0001415889-24-020780.txt : 20240805
0001415889-24-020780.hdr.sgml : 20240805
20240805183628
ACCESSION NUMBER: 0001415889-24-020780
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240801
FILED AS OF DATE: 20240805
DATE AS OF CHANGE: 20240805
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mirabelli Mary
CENTRAL INDEX KEY: 0001937525
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41599
FILM NUMBER: 241176450
MAIL ADDRESS:
STREET 1: C/O GENELUX CORPORATION
STREET 2: 2625 TOWNSGATE ROAD, SUITE 230
CITY: WESTLAKE VILLAGE
STATE: CA
ZIP: 91361
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GENELUX Corp
CENTRAL INDEX KEY: 0001231457
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2625 TOWNSGATE ROAD, SUITE 230
CITY: WESTLAKE VILLAGE
STATE: CA
ZIP: 91361
BUSINESS PHONE: 805-267-9889
MAIL ADDRESS:
STREET 1: 2625 TOWNSGATE ROAD, SUITE 230
CITY: WESTLAKE VILLAGE
STATE: CA
ZIP: 91361
FORMER COMPANY:
FORMER CONFORMED NAME: GENELUX CORP
DATE OF NAME CHANGE: 20030508
4
1
form4-08052024_100824.xml
X0508
4
2024-08-01
0001231457
GENELUX Corp
GNLX
0001937525
Mirabelli Mary
C/O GENELUX CORPORATION
2625 TOWNSGATE ROAD, SUITE 230
WESTLAKE VILLAGE
CA
91361
true
false
false
false
0
Common Stock
2024-08-01
4
A
0
39541
0
A
52001
D
Stock Option Right to Buy)
1.54
2024-08-01
4
A
0
50469
0
A
2034-07-31
Common Stock
50469
50469
D
Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders.
The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders.
/s/ Thomas Zindrick, J.D., Attorney-in-Fact
2024-08-05